The absence of a protein that activates the body’s antiviral defenses can cause a rare rheumatoid-like autoinflammatory condition called TBK1, which is treatable with an existing FDA-approved drug.
Scientists found that a rare rheumatoid-like autoinflammatory condition that is treatable with a class of drugs known as TNF (tumor necrosis factor) inhibitors.
PD-1 Inhibitor OK d as Adjuvant Therapy for Bladder Cancer medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
U S Food and Drug Administration Approves Opdivo® for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.